AestheticsFeatured ArticlesPsoriasisThe Latest

Psoriasis Clearance Motivates Patients to Seek Cometic Procedures, Study Finds

By January 28, 2021March 25th, 2021No Comments

Featured Article

Featured Article

Patients with moderate to severe psoriasis who achieved 75% or greater reduction in BSA showed an increased uptake in cosmetic procedures and this increase correlated with a reported improvement in quality of life after psoriasis clearance, the authors found.

More Psoriasis Articles

Patients with moderate to severe psoriasis who achieved 75% or greater reduction in BSA showed an increased uptake in cosmetic procedures and this increase correlated with a reported improvement in quality of life after psoriasis clearance, the authors found.

Heather Onorati

A significant reduction in psoriasis body surface area (BSA) may motivate patients to seek cosmetic procedures, according to findings from a recent study, “Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement.”

Patients with moderate to severe psoriasis who achieved 75% or greater reduction in BSA showed an increased uptake in cosmetic procedures and this increase correlated with a reported improvement in quality of life after psoriasis clearance, the authors found.

Researchers lead by Michelle Walters, M.D., Harbor-UCLA Medical Center, Torrance, Calif., examined the relationship between improvement in quality of life following a reduction in BSA and the use of cosmetic procedures. They identified 138 patients with a history of moderate to severe psoriasis from  the Dermatology Institute and Skin Cancer Center in Santa Monica, Calif., and surveyed them using the Dermatology Life Quality Index (DLQI), adding an additional 5 questions related to the patients’ cosmetic procedures.

Of the group, 119 patients said they had never before undergone a cosmetic procedure due to their psoriasis. All of the patients responded that their quality of life had improved with their psoriasis treatment, and the majority (91%) said this improvement motivated them to undergo the cosmetic procedure.

The most common cosmetic procedures sought by these patients were neurotoxins, soft tissue augmentation and chemical peels. In addition, 79% of the patients purchased skincare products dispensed through the office.

“The improvement in quality of life following treatment of psoriasis with systemic or biologic agents noted in our study reflects results from previous studies,” the authors note. However, the authors state that there have been no studies that have examined a correlation between the improvement in quality of life following psoriasis treatment and an uptake in surgical or nonsurgical cosmetic procedures.

“We found that a common motive for patients who sought cometic procedures was the desire to further improve their quality of life after clearance of their psoriasis,” the authors say. They add that this study indicates that successful treatment of the condition may be a motivator for patients to seek cosmetic procedures for other skin indications.

Heather Onorati is an experienced medical writer and editor with more than 20 years covering the dermatology industry

Discover new clinical findings in Psoriasis.  View the latest articles, case reports, supplements, CME activities, Podcast episodes and more.

 

You May Also Like

Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Aesthetics Is Changing. Here’s What We’re Seeing?

JDD Re:View With Dr. Beer

| Aesthetics, Alopecia, Featured Articles, Hair, JDD Re:View, Latest News | No Comments
Hair Disorders and Treatments   Hair treatments have proliferated in the past several years. While prior treatment options were limited to topical minoxidil and oral finasteride for androgenetic alopecia (AGA),…

Proximal Subungual Onychomycosis in the Immunocompetent: A Case Report and Review of the Literature

| Featured Articles, Latest News, Nails | No Comments
From the Vault: Pulled due to increased interest in rare onychomycosis presentations This case report dates back to JDD’s April 2018 issue. It’s a case report describing a healthy 51-year-old…
Journal of Drugs in Dermatology JDD Article about Brodalumab’s 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence

Brodalumab’s 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence

| Featured Articles, Latest News, Psoriasis | No Comments
Updated long term and real world evidence on efficacy and safety This is a must-read JDD article on brodalumab in plaque psoriasis. The review summarizes long term clinical trial findings,…

Leave a Reply